Sporadic amyotrophic lateral sclerosis associated with Asp90Ala CuZn-superoxide dismutase mutations in Russia

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 100, Issue 1, 2000, Pages 44-47

  Skvortsova, V I ^a   Limborskaya, S A ^a   Slominsky, P A ^a   Levitskaya, N I ^a   Levitsky, G N ^a   Shadrina, M I ^a   Kondratyeva, E A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYL ALANYL HISTIDYL LYSINE; ASPARTYL-ALANYL-HISTIDYL-LYSINE; OLIGOPEPTIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; ENZYMOLOGY; ETHNOLOGY; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; MALE; METABOLISM; MIDDLE AGED; POINT MUTATION; RUSSIAN FEDERATION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; POINT MUTATION; RUSSIA; SUPEROXIDE DISMUTASE;

EID: 0003161991     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Andersen P.M., Nilsson P., Ala-Hurula V. et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation of CuZn superoxide dismutase. Nat Genet 1995; 10: 61-66.
2. Andersen P.M., Forsgren L., Binzer M. et al. Autosomal-recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153-1172.
3. Andersen P.M., Nilsson P., Keränen M.-L., Forsgren I. et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723-1737.
4. Aran F.A. Reserches sur une maladie non encore décrite du sustéme musculaire (Atriphie musculaire progressive). Arch Gen Med 1850; 24: 5-35.
5. nd ed. London 1830.
6. Borchelt D.R., Lee M.K., Slunt Y.S. et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis. J Neurochem 1995; 64: 2366-2369.
7. Bowling A.C., Barkowsky E.E., McKenna-Yasek D. et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995; 64: 2366-2369.
8. th ed. Oxford 1962; 531.
9. Brooks B.R. El Escorial World Federation criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124 Suppl: 96-107.
10. Caroscio J.T., Calhoun W.F., Yahr M.D. Prognostic factors in motor neuron disease - a prospective study of longevity. F.C. Rose (ed.). Research progress in motor neuron disease. London 1994; 34-43.
11. Charcot J.M., Joffroy A. Deux cas atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moële épinere. Arch Physiol Norm Path 1869; 2: 744-760.
12. Chio A., Brignolio F., Meineri P., Schiffer D. Phenotypic and genotypic heterigeneity of dominantly inherited amyotrophic lateral sclerosis. Acta Neurol Scand 1987; 75: 277-282.
13. De Belleroche J., Leigh P.N., Clifford Rose F. Familial motor neuron disease. P. Leigh, M. Swash (eds.). Motor neuron disease. London: Springier-Verlag 1995: 35-51.
14. Deng H.X., Tainer J.A., Mitsumoto H., Ohnishi A. et al. Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1113-1116.
15. Duchenne de Boulogne G.B.A. Paralyse musculaire progressive de la langue, du voile du palais et des lévres: affection non encore décrite comme espéce morbide distincte. Arch Med Gen 1860; 16: 283: 431.
16. Emery A., Holloway S. Familial motor neuron disease. L.P. Rowland (ed.). Human motor neuron diseases. New York 1982; 139-147.
17. Esteban J., Rosen D.R., Bowling A.C. et al. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-998.
18. Forsgren L., Almay B.G.L., Holmgren G., Wall S. Epidemiology of motor neuron disease in Northern Sweden. Acta Neurol Scand 1983; 68: 20-29.
19. Gubbay S.S., Kahana E., Zilber N. et al. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232: 295-300.
20. Gurney M.E., Pu H., Chiu A.Y. et al. Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-1775. Comment in Science 1994; 264: 163-164. Comment in Science 1994; 266: 1586-1587.
21. Gurney M.E., Pu H., Chiu A.Y. et al. Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-1775. Comment in Science 1994; 264: 163-164. Comment in Science 1994; 266: 1586-1587.
22. Gurney M.E., Pu H., Chiu A.Y. et al. Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-1775. Comment in Science 1994; 264: 163-164. Comment in Science 1994; 266: 1586-1587.
23. Havekamp L.J., Appel V., Appel S.H. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707-719.
24. Horton B.A., Eldridge R., Brody J.A. Familial motor neuron disease. Evidence for at least three different types. Neurology 1976; 26: 460-465.
25. Hudson A.J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. [Review]. Brain 1981; 104: 217-247.
26. Jackson M., Al-Chalabi A., Enayat Z.E. et al. Mutations in SOD-1 in sporadic ALS [abstract]. Am J Hum Genet 1996; 59: Suppl A: 265.
27. Jones C.T., Swingler R.J., Brock D.J.H. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and detection o Ile113Thr in three others. Hum Mol Genet 1994; 3: 649-650.
28. Jones C.T., Shaw P.J., Chari G., Brock D.J.H. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994; 8: 329-330.
29. Jones C.T., Swingler R.J., Simpson S.A., Brock D.J.H. Superoxide dismutase mutations in an unselecyed cohort of Scottish amyotrophic lateral sclerosis. J Med Genet 1995; 32: 290-292.
30. Kaplan J.P., Brooks B.R., Mitsumoto H. et al. Atypical familial amyotrophic lateral sclerosis [abstract]. Am J Hum Genet 1996; 59 Suppl: A265.
31. Kawamatha J., Shimohama S., Hasegawa H. et al. Deletion and point mutations in superoxide dismutase-1 gene in amyotrophic lateral sclerosis [abstract]. Xith TMIN International Symposium: Amyotrophic lateral sclerosis, Progress and Perspectives in basic research and clinical application. Tokyo 1995; 14.
32. Kristensen M., Melgaard B. Motor neuron disease. Prognosis and epidemiology. Acta Neurol Scand 1977; 56: 299-308.
33. Kurland L.T., Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis. Familial aggregations indicative of dominant inheritance. Part I, II. Neurology 1955; 5: 182-196; 249-268.
34. Lambert E.H. Electromyography in amyotrophic lateral sclerosis. F. Norris, L. Kurland (eds.). Motor neuron diseases: research on amyotrophic lateral sclerosis and related disorders. New York 1969; 135-153.
35. Lopez-Vega J.M., Calleja J., Combarros O. et al. Motor neuron disease in Cantabria. Acta Neurol Scand 1988; 77: 1-5.
36. Mulder D.W., Kurland L.T., Offord K.P., Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986; 36: 511-517.
37. Norris F.N., Callachini P.R., Fallat R.J. et al. Administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721-728.
38. Rabizadeh S., Gralla E.B., Borchelt D.R. et al. Mutations associated with amyotrophic lateral sclerosis from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995; 92: 3024-3028.
39. Radunovic A., Leigh P.N. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis. Correlation between genotype and clinical features. [Review]. J Neurol Neurosurg Psychiat 1996; 61: 565-572.
40. Robberecht W., Aguirre T., Van-den-Bosch L. et al. D90A heterozygosity in SOD-1 gene in associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996; Nov: 47: 5: 1336-1339.
41. Rosati G., Pinna L., Granieri E. et al. Studies on eoidemiological, clinical and ethiological aspects of ALS disease in Sardinia. Southern Italy. Acta Neurol Scand 1977; 55: 231-244.
42. Rosen D.R., Siddique T., Patterson D. et al. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. [published erratum appears in Nature 1993; 364: 362] [see comments]. Nature 1993; 362: 59-62. Comment in: Nature 1993; 362: 20-21.
43. Rosen D.R., Siddique T., Patterson D. et al. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. [published erratum appears in Nature 1993; 364: 362] [see comments]. Nature 1993; 362: 59-62. Comment in: Nature 1993; 362: 20-21.
44. Rowland L.P. Diverse forms of motor neuron diseases. L.P. Rowland (ed.). Human motor neuron diseases. New York: Raven Press 1982; 1-13.
45. Spiller W.G. Primary degeneration of the pyramidal tracts: a study of eight cases with necrophy. Univ Pa Med Bull 1904; 17: 390-395.
46. Suthers G., Laing N., Wilton S. et al. "Sporadic" motor neuron disease due to familial SOD1 mutation with low penetrance [letter]. Lancet 1994; 344: 1773.
47. Swash M., Swartz M.S. Motor neuron disease: The Clinical Syndrome. P. Leigh, M. Swash (eds.). Motor neuron disease. London: Springler-Verlag 1995; 1-17.
48. Tsuda T., Munthasser S., Fraser P.E. et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994; 13: 727-736.
49. Williams D.B., Floate D.A., Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215-230.
50. Wilson S.A.K. Neurology. London: Edward Arnold 1940; 1028-1029.